SoftBank disclosed a 20.45M share position in PacBio (PACB) and 14.67M share position in Recursion Pharmaceuticals (RXRX) in a regulatory filing detailing its holdings as of December 31, 2024. SoftBank also reported a new position of 628,553 shares of Better Home & Finance (BETR). The fund exited its stakes in IonQ (IONQ) and DoorDash (DASH).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACB:
- Airbnb, Moderna report Q4 results: Morning Buzz
- PacBio should return to growth over time, says Canaccord
- PacBio price target lowered to $3.50 from $4 at TD Cowen
- Pacific Biosciences: Strategic Growth Amidst Funding Challenges Supports Buy Rating
- PacBio Navigates Financial Challenges with Strategic Advances